Eligibility for vaccination opens to everyone 16 and older beginning Wednesday, and dose allocations to Maine have risen.
vaccine
Vaccine sites in Maine gear up for busiest week to date
A record number of doses, coupled with the state opening eligibility to anyone 16 and older, has providers looking ahead to next week.
Mainers younger than 30 driving surge in new COVID-19 cases
Public health officials are warning that the rising number of cases in Maine and across the country could threaten efforts to control the disease with steady progress on vaccinations.
Maine’s growing surge in cases threatens vaccination progress
The prevalence of highly transmissible variants coupled with increasing travel and pandemic fatigue have led to a steady increase in new COVID-19 cases, in Maine and many other states.
Biden launches community corps to promote COVID vaccinations
The Biden administration is unveiling a coalition of community, religious and celebrity partners to promote COVID-19 shots as it seeks to overcome vaccine hesitancy
All Mainers age 16 and older eligible for COVID-19 vaccinations on Wednesday
Gov. Janet Mills says it may still take some time to schedule an appointment, even as vaccine allocations for Maine from the federal government continue to increase.
Batch of Johnson & Johnson vaccine goes to waste after failing quality check
The drugmaker, which pledged to provide 20 million doses by the end of March and 80 million more by the end of May, says it is still ‘aiming to deliver those doses.’
Will we need annual COVID-19 shots, or booster shots? Maybe.
Scientists are studying how long vaccines provide immunity and how well they work against the coronavirus variants to determine the need for follow-up shots.
Maine colleges will encourage, not require, students to get vaccinated
Several campuses say they are strongly encouraging their students and staff to get vaccinations but won’t require them as long as the vaccines are authorized only for emergency use by the FDA.
BioNTech raises COVID vaccine target to 2.5 billion doses
The company also announced it’s developing two new formulations: a ready-to-use vaccine that can be stored at fridge temperatures and a freeze-dried version that could be stockpiled.